OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments
Yuan-Li Tsai, Marcel Arias-Badia, Theresa A. Kadlecek, et al.
Immunity (2023) Vol. 56, Iss. 12, pp. 2682-2698.e9
Open Access | Times Cited: 7
Yuan-Li Tsai, Marcel Arias-Badia, Theresa A. Kadlecek, et al.
Immunity (2023) Vol. 56, Iss. 12, pp. 2682-2698.e9
Open Access | Times Cited: 7
Showing 7 citing articles:
The Tumor Microenvironment: Signal Transduction
Xianhong Zhang, Haijun Ma, Yue Gao, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 438-438
Open Access | Times Cited: 8
Xianhong Zhang, Haijun Ma, Yue Gao, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 438-438
Open Access | Times Cited: 8
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells
Hao‐Qi Wang, Fei Li, Yuanyuan Feng, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113971-113971
Closed Access
Hao‐Qi Wang, Fei Li, Yuanyuan Feng, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113971-113971
Closed Access
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
Sébastien Viel, Éric Vivier, Thierry Walzer, et al.
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 2
Sébastien Viel, Éric Vivier, Thierry Walzer, et al.
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 2
The emerging roles of liquid–liquid phase separation in tumor immunity
Yuan‐Tong Liu, Lin-Yu Cao, Zhi‐Jun Sun
International Immunopharmacology (2024) Vol. 143, pp. 113212-113212
Closed Access
Yuan‐Tong Liu, Lin-Yu Cao, Zhi‐Jun Sun
International Immunopharmacology (2024) Vol. 143, pp. 113212-113212
Closed Access
Roles of TULA-family proteins in T cells and autoimmune diseases
Hua Wang, Patrick Concannon, Yan Ge
Genes and Immunity (2024)
Closed Access
Hua Wang, Patrick Concannon, Yan Ge
Genes and Immunity (2024)
Closed Access
